Laura Bass
About Laura Bass
Company
Currently, Laura Bass is working at Bristol-Myers Squibb. She holds multiple roles, including Vice President of Global Quality Analytical Sciences & Technology in Devens, Massachusetts, as well as Executive Director and Executive Director of Analytical Sciences and Technology in the Greater Boston Area.
Title
Laura Bass is the Vice President of Global Quality Analytical Sciences & Technology at Bristol-Myers Squibb.
Education and Expertise
Laura Bass earned a Doctor of Philosophy (PhD) in Bioinorganic Chemistry from Washington University in St. Louis, where she studied from 1989 to 1994. She also holds a Bachelor of Science (BS) in Chemistry from the University of Missouri-Columbia, where she studied from 1985 to 1989.
Professional Background
Laura Bass has an extensive background in the pharmaceutical and biopharmaceutical industry. She worked at Pfizer in various roles, including Scientist (2000-2003), Director (2003-2010), and Senior Director (1999-2015) in the Greater St. Louis Area. She also had a research role at Monsanto (1998-1999) and was a Post-Doc at Washington University Medical School (1994-1997).
Responsibilities and Contributions
At Bristol-Myers Squibb, Laura Bass authored the analytical sections of Biologics License Applications (BLAs) and New Drug Applications (NDAs). She is responsible for responding to Health Agency queries related to analytical methods and specifications. She owns the Market Life Stability programs, ensuring product stability throughout their market life. Additionally, Bass partners with commercial Quality Control (QC) labs to ensure compliant execution of analytical methods across a global testing network and has been defining the commercial analytical Chemistry, Manufacturing, and Controls (CMC) strategy for both large and small molecule biopharmaceuticals since 2018.